Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
Eduard Roussel, Maarten Albersen, Vital Hevia(Hospital Universitario Ramón y Cajal), Aaron Bradshaw(University of California San Diego), Alessandro Larcher(IRCCS Ospedale San Raffaele), Enrico Checcucci(University of Turin), Francesco Porpiglia(University of Turin), Benoit Beuselinck(Universitair Ziekenhuis Leuven), Matthias Heck(TUM Klinikum), Umberto Capitanio(Vita-Salute San Raffaele University), M. D’Anna(Hospital Clínic de Barcelona), Michele Marchioni(University of Chieti-Pescara), Annelies Verbiest(KU Leuven), Andrea Minervini(Azienda Ospedaliero-Universitaria Careggi), Riccardo Campi(University of Florence), Riccardo Autorino(Rush University Medical Center), Thomas Amiel(Technical University of Munich), Maximilian C. Kriegmair(University Medical Centre Mannheim), José Rubio(Fundación Instituto Valenciano de Oncología), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Estefanía Linares-Espinós(Hospital Universitario La Paz), Siska Van Bruwaene(AZ Groeninge), Mireía Musquera(Surgical Specialties (Canada)), Alessandro Antonelli(University of Verona), Nicola Pavan(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Fady Ghali(University of California San Diego), Francesco Claps(University of Trieste), Alessandro Veccia(University of Verona), Ithaar Derweesh(Rush University Medical Center), Maria C. Mir(Fundación Instituto Valenciano de Oncología), Margaret Meagher(University of California San Diego), Andrea Mari(Azienda Ospedaliero-Universitaria Careggi), Carlotta Palumbo(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 50
Related Papers
Urology practice during the COVID-19 pandemic
|Minerva Urologica e Nefrologica|2020|256
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
|European Urology|2020|207
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
|Annals of Oncology|2009|205
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190